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Abstract
Background: All human chromosomes are capped by tandem repeat (TTAGGG)n sequences that protect them against
end-to-end fusion and are essential to chromosomal replication and integrity. Therefore, after a chromosomal breakage,
the deleted chromosomes must be stabilized by retaining the telomere or acquiring a new cap, by telomere healing or
telomere capture. There are few reports with molecular approaches on the mechanisms involved in stabilization of 18q
terminal deletions.
Results: In this study we analyzed nine patients with 18q terminal deletion identified by G-banding and genomic array.
FISH using PNA probe revealed telomeric signals in all deleted chromosomes tested. We fine-mapped breakpoints with
customized arrays and sequenced six terminal deletion junctions. In all six deleted chromosomes sequenced, telomeric
sequences were found directly attached to the breakpoints. Little or no microhomology was found at the breakpoints
and none of the breaks sequenced were located in low copy repeat (LCR) regions, though repetitive elements were
found around the breakpoints in five patients. One patient presented a more complex rearrangement with two deleted
segments and an addition of 17 base pairs (bp).
Conclusions: We found that all six deleted chromosomes sequenced were probably stabilized by the healing
mechanism leading to a neotelomere formation.
Keywords: Terminal 18q deletion, Breakpoint sequencing, Telomere healing, Telomere capture, Neotelomere,
Stabilization mechanism
Background
While interstitial deletions involve two breaks in the
same chromosome arm, terminal deletions are caused by
only one break leading to genomic loss. Terminal dele-
tions of the long arm of chromosome 18 produce a
highly variable phenotype. Among the most commonly
reported features are growth deficiency, microcephaly,
facial and limb abnormalities, genitourinary malforma-
tions, neurological abnormalities, hearing abnormalities
and developmental delay with intellectual disability [1,2].
The phenotypic variability is related to the heterogeneity
of the deletion size and gene content [3]. The deletions
vary in size, but proximal breakpoints have been mainly
described within bands 18q21.2 to 18q22.2, and does not
correlate completely with the severity of clinical findings
[3-5]. The region 18q22-q23 has been implicated as
critical in development impairment but a deletion in
this region leads only to a susceptibility to the clinical
features, since not all patients with this region deleted
have the same clinical findings [4-6].
All human chromosomes are capped with around 3-
20 kb of tandem repeat (TTAGGG)n sequences and, im-
mediately adjacent to this region, there is a segment of
around 100-300 kb, the telomere-associated repeat
(TAR) sequences [7]. These TAR sequences share hom-
ology with other chromosome ends [8,9]. Chromosome
specific DNA sequences are located proximal to the
TAR sequences [10]. Since telomeres are essential for
chromosomal stabilization after breakage, the deleted
chromosomes must retain the telomere or acquire a new
cap [11,12]. Two main mechanisms were proposed to
stabilize chromosome ends with terminal deletions: (1)
telomere healing in which telomerase directly adds de
novo telomeric repeats to unique nontelomeric DNA
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and (2) telomere capture in which the telomere is cap-
tured from another chromosome due to homology of
sequence by a recombination-based mechanism, result-
ing in a derivative chromosome [11,13]. It is assumed
that sequence homology of TAR regions between non-
homologous chromosomes may influence telomere
capture events [8]. Due to the development of molecu-
lar techniques, a variety of cryptic telomeric aberrations
has been identified and showed that many apparently
pure terminal deletions are in fact terminal deletions
stabilized as derivative chromosomes by telomere cap-
ture [2,14,15]. The mechanism by which telomerase
first recognizes a telomere or a broken chromosomal
end is unknown [13]. Human genome subtelomeric re-
gions are of particular interest in clinical cytogenetics,
since they are the most gene-rich regions in the entire
genome [13,16]. Therefore, characterization of telomeric
regions is important for our understanding of the relation-
ship between chromosome structure and function [9] and
because chromosomal rearrangements involving telomeres
result in a number of clinical conditions, including intel-
lectual disability [17].
Thanks to recent advances in molecular genetic tech-
niques, a better characterization of terminal deletions is
possible [18,19]. The studies have demonstrated that several
terminal deletions considered simple are not as simple as
first thought and can present microduplication, inversion
or addition of some base pairs, or they are in fact interstitial
deletions. Sequencing of 18q terminal deletions may also
help to understand the clinical variability presented by the
patients. In this study we studied nine patients with
18q terminal deletions using G-banding, array tech-
niques and FISH with telomeric probe. In six patients
breakpoint sequencing was performed to determine the
mechanisms involved in the stabilization of the deleted
chromosome.
Patients studied
Nine patients (7 females and 2 males) with 18q terminal
deletion, detected by conventional karyotyping using G-
banding and/or genomic array, were selected for the
study.
Results
G-banding showed de novo terminal 18q deletions in
all patients. FISH using PNA probes performed in
seven patients revealed telomeric signals in both arms
of the deleted chromosomes (Figure 1 and Table 1).
The data from SNP-array (for 8 patients) and from
custom CGH-array (for 7 patients) are presented in
Table 1. High resolution CGH-array narrowed the region
around chromosome breakpoints to a few hundred base
pair. For six patients (P1 to P6), breakpoint definition
was performed and sequencing data from the PCR
Figure 1 FISH results using Telomere PNA FISH Kit/FITC for patients with 18q terminal deletions showing telomeric signals in normal chromosomes 18
and in deleted chromosomes (arrows) in patients P1 (A), P2 (B), P5 (C), P7 (D) and P8 (E).
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products were aligned to the reference genome. In these
patients, telomeric sequences (TTAGGG)n were added dir-
ectly after the 18q breakpoint (Figure 2). A 100 bp region
each side of the breakpoints was chosen to verify the pres-
ence of repetitive elements around them. In P1, the sequen-
cing junction revealed 3 bp (genomic coordinates:
60,814,620-3) microhomology at the breakpoint between
the chromosome 18 reference sequence and the telomeric
DNA sequence (Figure 2A-D), without repetitive elements
around the breakpoint. Patients P2, P5 and P6 presented
2 bp of microhomology at the breakpoint (genomic coordi-
nates: 59,487,156-8; 56,048,454-6 and 62,768,931-3, respect-
ively) (Figures 2E, H and I). Around their breakpoints,
repetitive elements SINE/Alu (for P2), LINE/L1 (for P5)
and DNA/hAT-Tip100 (for P6) were found. In these pa-
tients the precise site of healing could not be precisely de-
termined due to presence of two or three nucleotides of
microhomology (yellow) that are shared between the gen-
ome reference and the telomere sequence in the breakpoint
region. Patient 3 (P3) presents only 1 bp of microhomology
(57,712,662), and repetitive elements were found around
the breakpoint - DNA (hAT-Charlie) (Figure 2 F). In patient
4 (P4) the sequencing junction revealed three breaks, two
of them resulting in an interstitial 8,625 bp deletion
(57,815,639-57,824,623) with the addition of 17 nucleotides,
not aligned to the 18q reference genome, followed by a nor-
mal sequence of chromosome 18q (57,824,264-57,824,310)
with a terminal deletion where telomeric sequences were
attached (Figure 2G). SINE/MIR sequences were found
around the first breakpoint and LINE/L1 and simple re-
peats were found around the second breakpoint. There was
insufficient material to perform array and sequencing for
the other three cases (P7 to P9).
Discussion
Recently, high-resolution genomic analysis in patients with
18q terminal deletions have revealed a high variability in
breakpoints and deleted regions, pointing to a contiguous
gene syndrome [16,20]. Array results showed breakpoints
in four different bands in our patients: four out of eight at
18q21.32 (57,714,859-58,939,925), some very close to each
other, two at 18q21.33 (59,488,412 and 60,814,632), one at
18q21.31 (56,046,905) and one at 18q22.1 (62,769,761).
In this study seven patients presented telomeric se-
quences (TTAGGG)n in the long arm of the deleted chro-
mosomes as shown by FISH with telomere probe. The
sequencing of 18q terminal deletions in six patients re-
vealed that the breaks were probably stabilized by a healing
mechanism in which the telomerase enzyme synthesized a
de novo telomere in the truncated chromosome at the
breakpoints creating a neotelomere. There are other cases
described in the literature stabilized by the same mechan-
ism in different chromosomes with terminal deletions
[10,11,13,21,22]. Although the deletions stabilized by telo-
mere capture from another chromosome forming a deriva-
tive chromosome reported in the literature presented with
DNA single copy sequences from both chromosomes
[10,15,23], the possibility of the capture of only the
(TTAGGG)n telomere sequences of other chromosomes,
simulating a neotelomere formation cannot be ruled out.
Luo et al [24] studied three cases with 18q terminal dele-
tion and observed that the breakpoints were distributed
throughout the end of the chromosome, as previously de-
scribed in other studies [20]. In one of the cases, the
stabilization mechanism was consistent with NHEJ between
double-strand breaks in two different chromosomes [24].
Many factors may contribute to make some regions of
the chromatin more susceptible to breaks and rearrange-
ments, such as the presence of enriched tandem repeats at
chromosome ends, fragile DNA sequences, LCRs, concen-
tration of particular repetitive sequences and motif se-
quences [24-26].
None of the six breaks sequenced in our patients were
mediated by LCRs since they were absent in the breakpoint
Table 1 Breakpoint definition data using G-banding, SNP-array, custom array CGH and FISH results with PNA probe in
patients with 18q terminal deletion
Patient G-banding karyotype and SNP-array (Affymetrix) Custom array CGH (Agilent) Differences between
the coordinates of
breakpoints
FISH
P1 46,XY,del(18)(q21.33)dn.arr 18q21.33q23(60,814,531-78,015,057) × 1 arr 18q21.33q23(60,814,632-78,015,147) × 1 101 bp +
P2 46,XX,del(18)(q21.33)dn.arr 18q21.33q23(59,488,812-78,015,057) × 1 arr 18q21.33q23(59,488,412-78,015,147) × 1 400 bp +
P3 46,XX,del(18)(q21.32)dn.arr 18q21.32q23(57,712,098-78,015,057) × 1 arr 18q21.32q23(57,714,859-78,015,147) × 1 2761 bp +
P4 46,XX,del(18)(q21.32)dn.arr 18q21.32q23(57,818,459-78,015,057) × 1 arr 18q21.32q23(57,814,054-78,015,147) × 1 4405 bp N
P5 46,XY,del(18)(q21.31)dn.arr 18q21.31q23(56,044,470-78,015,057) × 1 arr 18q21.31q23(56,046,905-78,015,147) × 1 2435 bp +
P6 46,XX,del(18)(q22.1)dn.arr 18q22.1q23(62,772,720-78,015,057) × 1 arr 18q22.1q23(62,769,761-78,015,147) × 1 2959 bp +
P7 46,XX,del(18)(q21.33)dn N +
P8 46,XX,del(18)(q21.32)dn.arr 18q21.32q23(58,641,269-78,015,057) × 1 N +
P9 46,XX,del(18)(q21.32)dn.arr 18q21.32q23(58,938,942-78,015,057) × 1 arr 18q21.32q23(58,939,925-78,015,147) × 1 983 bp N
(N) not performed, unavailable material; (+) signal telomere present by FISH.
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Figure 2 Steps in sequencing 18q terminal deletions for patient 1 (A-D) and data for the other patients (E-I). (A) CGH-array profile in custom slide
showing 18q21.33 terminal deletion for P1. Below, a schematic view of the breakpoint junction. The box, designated as “telomere cap” indicates the
telomere (TTAGGG)n sequence. Black arrows show location of PCR primers in different combinations (ATF3, ATF4, ATF5 with TelR2); (B) PCR result in
agarose gel 1.5% showing the fragment amplification using the three pairs of primers in P1 and no amplification in the male control (C) and
blank (B); (C) Sequencing result showing the breakpoint in 18q21.33 and the beginning of telomere sequences (underlined); Alignment of the
PCR products to the normal 18q sequence (above) and telomere sequences (below) showing microhomology (yellow) of 3 bp for P1 (D); 2 bp for P2
(E); 1 bp for P3 (F); 2 bp for P5 (H) and 2 bp for P6 (I); and a complex rearrangement with an interstitial deletion with addition of 17 bp (red) followed
by normal 18q sequence before the telomeric sequences, without microhomology, for P4 (G).
Guilherme et al. Molecular Cytogenetics  (2015) 8:32 Page 4 of 7
regions. LCRs were also not observed flanking the break-
points in patients with 9q and 4p deletions [10,21]. The
analysis of the region around the breakpoints revealed that
only in our patient 1, repetitive elements were not found.
Ballif et al [27] characterized breakpoint regions in four
patients with 1p36 terminal deletion and found that all the
breakpoints fall within repetitive DNA sequence elements.
Bonaglia et al [22] observed that only 13 out of 22 break-
points in chromosomes with 22q13 deletion fell inside
repetitive elements. Yatsenko et al [10] sequenced 43 break-
points within the 9q34 region and the analysis of these junc-
tions revealed that they were concentrated in regions with a
high incidence of repetitive elements. Similarly, some of the
breakpoints from our patients (P2, P4′s second break, P5
and P6) were located inside repetitive elements. However, it
is unclear how repetitive elements participate in recombin-
ation events or DNA replication and repair [10].
Few (1 – 3 bp) or no microhomology was found in
the breakpoints in our six patients who had their break-
point sequenced. Similar lengths of microhomology
were detected at breakpoint junctions sequenced from
14 terminal deletions of different chromosome ends
[24]. In vitro studies have demonstrated that mamma-
lian telomerase is capable of de novo telomere addition
with as little as a single bp of homology or none to the
template, suggesting that 3’ end pairing is not essential
[28,29]. In fact, in a small proportion of terminal deletion
breakpoints, microhomology was not found [12,13,21],
similar to observed in our patient 4. Taking all these data,
microhomology seems not to be essential for telomerase
elongate truncated chromosomes.
The microhomology sequences in our five patients are
homologous to (TTAGGG)n telomere repeats and may re-
flect the template-driven replication mechanism, in which
the telomerase utilizes to replicate chromosome ends [30].
However, the site of healing cannot be precisely identified
due to the microhomology between telomeric and break-
point 18q sequences. Patient 4 presented an unexpected
18q terminal deletion with addition of 17 bp followed by
an interstitial deletion in the first break and a terminal de-
letion. This event is probably the result of multiple steps:
two breaks causing interstitial deletion with the addition of
17 bp that was stabilized by NHEJ (non-homologous end
joining) followed by 18q normal sequence and a third break
resulting in a terminal deletion stabilized by healing mech-
anism leading to the rearrangement observed. Similar to
our study, other studies also found unexpected rearrange-
ments at the breakpoint junctions such as interstitial dele-
tion, additional nucleotides and inversion [10-12,22,24].
Conclusion
Telomeric sequences must be present in both chromo-
some arm ends showing its importance to the stabilization
of the chromosomes deleted. Breakpoint analysis is useful
in elucidating the molecular mechanisms by which ter-
minal deletions are stabilized. Few cases with terminal
deletion 18q had their breakpoints determined at the
base pair level. In our six patients with 18q breakpoint
sequenced, telomeric sequences (TTAGGG)n attached
directly in the breakpoint were found indicating
chromosome stabilization by telomere healing mechan-
ism originating a neotelomere. In four cases repetitive
elements were present in the breakpoint junctions. One
of the patients presented a more complex rearrangement
suggesting that in rare cases stabilization of a terminal
deletion is not as simple as first thought.
Methods
Classical and molecular cytogenetics
Chromosome analysis was performed first on 72-h
lymphocyte cultures according to standard procedures.
FISH (Fluorescence in situ Hybridization) using com-
mercial probe Telomere PNA FISH Kit/FITC (Peptide
nucleic acid) Dako® was performed according to manu-
facturing guidelines.
Molecular studies
DNA was isolated from peripheral blood using Gentra
Puregene kit (Qiagen Sciences Inc., Germantown, MD,
USA). Samples were genotyped using the Affymetrix
Genome-Wide Human SNP Nsp/Sty 6.0 array (Affymetrix
Inc., Santa Clara, CA, USA) and data were analyzed with
the Chromosome Analysis Suite (ChAS) Software (Affy-
metrix Inc., Santa Clara, Calif., USA), using annotation
GRCh37/hg19. To define the breakpoints with a higher
resolution, custom 8 × 60 K CGH-arrays (Agilent Tech-
nologies) were designed with probes targeting the break-
points detected by clinical SNP-array (Affymetrix), using
Agilents’ SureDesign program (https://earray.chem.agi-
lent.com/suredesign/). The custom slides presented
with a total of 62,976 probes targeted at 30 kb intervals
surrounding the previously determined breakpoints.
Control probes were also added for other chromosomes
at a lower density. The unique identifiers (AMADIDs)
for the array designs are 49352 and 67473 (designs
available upon request). The experiments were performed
according to manufacturing guidelines. The slides were
scanned using DNA microarray Scanner with Surescan of
high resolution (Agilent Technologies) and signal inten-
sities were evaluated using Feature Extraction Standard
Edition 6.5.0.58 (Agilent Technologies, Santa Clara, CA).
Breakpoint’s analyses were performed using Agilent Cyto-
genomics software.
In order to amplify breakpoint junctions, unique se-
quence forward primers, complementary to the intact
(non-deleted) 18q chromosomal region, were designed
using Primer3 software (http://simgene.com/Primer3)
(Additional file 1: Table S1). These primers were paired
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with a reverse primer complementary to the telomeric
repeat sequence that has been used in other studies: TelR2
5’- TATGGATCCCTAACCCTGACCCTAACCC-‘3 (Flint
et al, 1994; Luo et al. 2011). Long Range PCR (Takara®,
Japan) was performed with 5.0 μl PCR buffer (10x), 4.0 μl
dNTP (2.5 mM each), 5.0 μl of each primer (2 μM), 7.0 μl
Betaine (5 M), 0.25 μl Ex Taq (5 U/μl) and 1.0 μl of DNA
template (100 ng). PCR conditions for amplifying terminal
deletions were: 94°C for 1 min; 10 cycles at 94°C for 30s,
65°C for 1 min (decreasing 1.0°C per cycle), 72°C for
3 min; 20 cycles at 94°C for 30s, 59°C for 1 min, 72°C for
3 min; and the final extension at 72°C for 5 min. PCR
products were purified from 1.5% agarose gels using the
QIAquick Gel extraction kit (Quiagen) and the breakpoint
junctions were sequenced in ABI PRISM 3500xl genetic
analyzer (Life Technologies). A male control DNA sample
was used in parallel in every reaction and no amplification
was obtained as expected. The sequence chromatograms
were analyzed using BioEdit software.
DNA sequences from the PCR products were aligned
to the human genome reference assembly (GRC37/
hg19) using BLAT tool on the UCSC Genome browser
(https://genome.ucsc.edu/). The regions flanking the
breakpoints (200 bp) of each patient were analyzed
using different programs to search for homologue se-
quence (BLAST), repetitive elements and low complexity
sequences (RepeatMasker database version 4.0.5).
Consent
Informed consents were obtained from the patients’
parents according to the Research Ethics Committee of
UNIFESP (CEP 0389/11).
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